Pharma and Patient Advocacy Groups Release Expensive Ads Ahead of Drug Price Negotiation Bill

Patient and prescription drug pricing advocacy groups, including Patients for Affordable Drugs Now, are pushing for drug legislation using expensive ad campaigns. Pharma is also injecting funds in an attempt to delay or avoid any price negotiation legislation. Ad campaigns are reaching seven figures as proponents of pricing reform call for Medicare to negotiate drug prices with manufacturers.

“If such negotiations are not allowed and prices don’t come down, Americans will continue to struggle to access their necessary medicines, particularly when they have life-threatening conditions like some cancers where pharmaceutical companies profit enormously and many Americans have been bankrupted.” Read more here.

(Source: Zachary Brennan, Endpoints News, 8/17/21)